BridgeBio Pharma
$0.99 B
Share price
Change (1 day)
Change (1 year)

Revenue for BridgeBio Pharma (BBIO)

Revenue in 2022 (TTM): $0.07 B

According to BridgeBio Pharma 's latest financial reports the company's current revenue (TTM) is $0.07 B. In 2021 the company made a revenue of $0.06 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BridgeBio Pharma from 2021 to 2022

Year Revenue Change
2022 (TTM)$0.07 B1.77%
2021$0.06 B